Starling Oncology, Inc. Increase (Decrease) in Derivative Assets and Liabilities
Starling Oncology, Inc. (DFPH) had Increase (Decrease) in Derivative Assets and Liabilities of $11.20 million as of 2020-03-13, per its 10-K/A filed 2021-05-24.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeAssetsAndLiabilities · last filed 2021-05-24
- 2020-03-13: Increase (Decrease) in Derivative Assets and Liabilities $11.20M.
| Period end | Increase (Decrease) in Derivative Assets and Liabilities |
|---|---|
| 2020-03-13 | $11.20M 10-K/A · filed 2021-05-24 |